ProSensa Holding N.V. Awarded Best Biotech Pipeline 2013 At The Rare & Orphan Advocacy and Research (ROAR) Awards

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Leiden, The Netherlands, Nov. 15, 2013 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) the Dutch biopharmaceutical company focusing on rare diseases with a high unmet medical need, has been awarded Best Biotech Pipeline 2013 in the Rare & Orphan Advocacy and Research (ROAR) Awards.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC